EDITORIAL
Why should pulmonologists be concerned with West Nile virus?
 
More details
Hide details
1
Assistant Professor in Pneumonology Medicine and Infectious Diseases, Respiratory Infection Unit, Department of Pneumonology Medicine, Aristotle University of Thessaloniki, General Hospital “G. Papanikolaou”
 
 
Corresponding author
Ioannis P. Kioumis   

Pneumonology Medicine, Aristotle University of Thessaloniki, General Hospital “G. Papanikolaou”
 
 
Pneumon 2013;26(1):17-19
 
KEYWORDS
 
REFERENCES (22)
1.
Danis K, Papa A, Theocharopoulos G, et al. Outbreak of West Nile Virus infection in Greece, 2010. Emerg Infect Dis 2010; 17:1968-1972.
 
2.
Papa A, Danis K, Tsergouli K, et al. Development type of IgG antibodies to West Nile virus. Arch Virol 2011; 156:1661-1663.
 
3.
Rossi SL, Ross TM, Evans JD. West Nile virus. Clin Lab Med 2010; 30:47-65.
 
4.
Lim SM, Koraka P, Osterhaus ADME, et al. West Nile virus: Immunity and pathogenesis. Viruses 2011; 3:811-828.
 
5.
Brault AC. Changing patterns of West Nile virus transmission: altered vector competence and host susceptibility. Vet Res 2009; 40(43)DOI: 10.1051/vetres/2009026.
 
6.
Kilpatrick AM. Globalization, land use and the invasion of West Nile virus. Science 2011; 334:323-327.
 
7.
Petersen LR, Marfin AA. West Nile virus: a primer for the clinician. Ann Intern Med 2002; 137:173-179.
 
8.
Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2:519-529.
 
9.
Huhn GD, Austin C, Langkop C, et al. The emergence of West Nile virus during a large outbreak in Illinois in 2002. Am J Trop Med Hyg 2005; 72:768-776.
 
10.
Lindsey NP, Staples JE, Lehman JA, et al. Midical risk factors for severe West Nile virus disease, United States 2008-2010. Am J Trop Med Hyg 2012; 87:179-84.
 
11.
Bigham AW, Buckingham KJ, Husain S, et al. Host genetic factors for West Nile virus infection and disease progression. PLoS ONE 2011; 6: e24745. doi:10.1371/journal.pone.0024745.
 
12.
Diamond MS. Progress on the development of therapeutics against West Nile virus. Antiviral Res 2009; 83:214-227.
 
13.
Relter P. West Nile virus in Europe: understanding the present to gauge the future. Eurosurveillance 2010; 15:pii=19508.
 
14.
Gubler DJ. The continuing spread of West Nile virus in the western hemisphere. Clin Infect Dis 2007; 45:1039-1046.
 
15.
Madden K. West Nile virus infection and its neurological manifestations. Clin Med & Research 2003; 1:145-150.
 
16.
Sejvar JJ, Lindsey NP, Campbell GL. Primary causes of death in reported cases of fatal West Nile fever, United States 2002- 2006. Vector Borne Zoonotic Dis 2011; 11:161-164.
 
17.
Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis outcome. Emerg Infect Dis 2006; 12:514-516.
 
18.
Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in south-central Ontario. CMAJ 2003; 168:1399-1405.
 
19.
Betensley AD, Joffery SH, Collins H, et al. Bilateral diaphragmatic paralysis and related respiratory complications ina patient with West Nile virus infection. Thorax 2004; 59:268-269.
 
20.
Paddock CD, Nicholson WL, Bhatnagar J, et al. Fatal hemorrhagic fever caused by West Nile virus in the United States. Clin Infect Dis 2006; 42:1527-1535.
 
21.
Bode AV, Sejvar JJ, Pape WJ, et al. West Nile virus disease: a descriptive study of 228 patients in a 4-county region of Colorado in 2003. Clin Infect Dis 2006; 42:1234-1240.
 
22.
Reisen WK, Fang Y, Martinez VM. Avian host and mosquito (Diptera: Culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission. Journal of Medical Entomology 2005; 42:367.
 
eISSN:1791-4914
ISSN:1105-848X
Journals System - logo
Scroll to top